Research Papers:

A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer

Yao Xue, Gaoxiang Ma, Zhensheng Zhang, Qiuhan Hua, Haiyan Chu, Na Tong, Lin Yuan, Chao Qin, Changjun Yin, Zhengdong Zhang _ and Meilin Wang

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:484-493. https://doi.org/10.18632/oncotarget.2861

Metrics: PDF 2845 views  |   HTML 2742 views  |   ?  


Yao Xue1,2,*, Gaoxiang Ma1,2,*, Zhensheng Zhang3,*, Qiuhan Hua1,2, Haiyan Chu1, Na Tong1, Lin Yuan4, Chao Qin5, Changjun Yin5, Zhengdong Zhang1,2 and Meilin Wang1,2

1 Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

2 Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China

3 Department of Urology, Changhai Hospital, The Second Military Medical University, Shanghai, China

4 Department of Urology, Jiangsu Province Hospital of TCM, Nanjing, China

5 Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

* These authors contributed equally to this work


Zhengdong Zhang, email:

Meilin Wang, email:

Keywords: antisense lncRNAs, MDC1-AS, expression regulation, bladder cancer

Received: August 20, 2014 Accepted: November 06, 2014 Published: November 06, 2014


Antisense long noncoding RNAs (lncRNAs) play important roles in regulating the expression of coding genes in post-transcriptional level. However, detailed expression profile of lncRNAs and functions of antisense lncRNAs in bladder cancer remains unclear. To investigate regulation of lncRNAs in bladder cancer and demonstrate their functions, we performed lncRNAs microarray analysis in 3 paired bladder cancer tissues. Further molecular assays were conducted to determine the potential role of identified antisense lncRNA MDC1-AS. As a result, a series of lncRNAs were differentially expressed in bladder cancer tissues in microarray screen. In a larger size of samples validation, we found that the expression levels of MDC1-AS and MDC1 was down-regulated in bladder cancer. After over-expression of MDC1-AS, increased levels of MDC1 were observed in bladder cancer cells. We also found a remarkably inhibitory role of antisense lncRNA MDC1-AS on malignant cell behaviors in bladder cancer cells EJ and T24. Subsequently, knockdown of MDC1 revealed that suppressing role of MDC1-AS was attributed to up-regulation of MDC1. In summary, we have identified a novel antisense lncRNA MDC1-AS, which may participate in bladder cancer through up-regulation of its antisense tumor-suppressing gene MDC1. Further studies should be conducted to demonstrate detailed mechanism of our findings.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 2861